Skip to main content

Table 2 The association between comorbidities and adjusted scores of QOL among stomach cancer survivors

From: The associations of comorbidities and consumption of fruit and vegetable with quality of life among stomach cancer survivors

  With Comorbidity, (without comorbidity) With HPT, (without HPT) With DM, (without DM) With HD, (without HD) With STR (without STR) With RD (without RD) With DD (without DD) With MD (without MD)
PF − 3.52*** −1.72*** −2.79*** −4.85*** −6.87*** −5.77*** − 2.54*** − 4.73***
(85.94) (83.26) (83.24) (83.86) (83.01) (83.48) (83.66) (84.16)
RF −2.67*** −1.15* −3.13*** −4.30*** − 6.42*** −5.90*** − 1.63*** − 4.38***
(91.89) (90.19) (90.36) (90.92) (90.31) (91.02) (91.48) (91.97)
EF −3.75*** −1.43*** − 3.00*** −4.98*** −5.84*** − 4.93*** − 3.28*** − 5.31***
(85.81) (85.53) (85.82) (86.49) (85.61) (85.78) (86.70) (87.01)
CF −4.45*** −1.04* −3.17*** −5.92*** −6.64*** −6.14*** −3.86*** − 6.45***
(83.18) (79.37) (79.24) (80.45) (78.97) (79.87) (81.35) (81.46)
SF −4.72*** −1.59** −2.70*** −6.26*** −8.21*** −8.80*** − 4.29*** −5.76***
(81.51) (77.33) (77.28) (78.60) (77.27) (77.87) (79.33) (79.00)
QL −6.03*** −3.18*** −4.63*** −7.21*** − 8.13*** −7.26*** − 4.28*** −6.37***
(68.41) (64.04) (63.66) (64.87) (63.25) (64.03) (64.98) (65.85)
FA 7.37*** 1.89*** 3.56*** 6.85*** 9.12*** 7.55*** 6.07*** 7.38***
(23.48) (28.18) (28.24) (27.09) (28.34) (27.80) (25.39) (26.14)
NV 0.41 0.42 0.84* 2.26*** 2.77*** 3.29*** 0.50* 1.60***
(4.72) (5.75) (5.56) (5.05) (5.29) (5.11) (4.80) (4.97)
PA 6.41*** 2.09*** 3.15*** 6.66*** 7.74*** 7.12*** 5.04*** 12.00***
(10.96) (16.09) (16.17) (15.24) (16.41) (15.79) (13.40) (12.79)
DY 5.53*** 2.01*** 2.87*** 7.93*** 8.18*** 13.88*** 3.83*** 5.23***
(12.48) (14.49) (14.97) (13.18) (14.95) (13.94) (13.99) (13.93)
SL 4.03*** 0.70 2.17*** 4.30*** 5.43*** 5.64*** 3.18*** 3.50***
(13.42) (18.22) (18.27) (16.99) (18.26) (17.74) (15.83) (16.32)
AP 1.81*** 0.74 2.02*** 4.19*** 5.00*** 5.78*** 2.07*** 3.10***
(10.45) (12.15) (12.68) (11.52) (12.45) (11.90) (10.85) (11.56)
CO 4.32*** −0.17 2.62*** 4.00*** 4.61*** 3.27*** 4.19*** 3.84***
(8.45) (11.47) (11.73) (11.22) (11.34) (11.39) (8.72) (10.14)
DI 2.68*** 1.11** 1.53** 2.60*** 2.66*** 4.29*** 3.12*** 2.99***
(9.37) (11.75) (11.49) (10.82) (11.53) (11.06) (8.86) (10.09)
FI 5.58*** 1.81* 2.19* 6.47*** 7.01*** 8.68*** 5.07*** 6.33***
(27.96) (32.01) (31.76) (30.40) (31.45) (31.04) (28.69) (29.67)
  1. Abbreviations: AP Appetite loss, BMI Body mass index, CF Cognitive functioning, CO Constipation, DD Digestive diseases, DI Diarrhea, DM Diabetes mellitus, DY Dyspnea; emotional functioning, EORTC QLQ-C30 European Organization for Research and Treatment quality of life version 3 questionnaire, FA Fatigue, FI financial difficulties, HD Heart diseases, HPT Hypertension, MD Musculoskeletal diseases, NV Nausea and vomiting, PA Pain, PF Physical functioning, QL Global health, QOL Quality of life, RD Respiratory diseases, RF Role functioning, SF Social functioning, SL Insomnia, SCS Stomach cancer survivors; stroke, STR
  2. Notes: *P,0.05, **P,0.01, ***P,0.001
  3. Multiple linear regression, adjusted for influence of sex, age, marital status, BMI, education, household income, time after diagnosis